US EditionPublished • loading... • Updated
29.7% Turnout Forces Delay: Palisade Bio's Special Meeting Adjourned Until October Due to Missing Quorum
Summary by stocktitan.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Carlsbad, CA, Sept. 26, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that the Company’s special meeting of stockholders held on September 26, 2025 at 10:00 a.m. Pacific Time was […] The post Palisade Bio Announces Adjournment …
29.7% Turnout Forces Delay: Palisade Bio's Special Meeting Adjourned Until October Due to Missing Quorum
Biotech firm Palisade Bio postpones special stockholder meeting after achieving only 29.68% participation vs required 33.3%. Meeting rescheduled for October 10, 2025, with proxy deadline October 9.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
